2 research outputs found
Near-IR Atlas of S0-Sa galaxies (NIRS0S)
An atlas of Ks-band images of 206 early-type galaxies is presented, including
160 S0-S0/a galaxies, 12 ellipticals, and 33 Sa galaxies. A majority of the
Atlas galaxies belong to a magnitude-limited (mB<12.5 mag) sample of 185 NIRS0S
(Near-IR S0 galaxy Survey) galaxies. To assure that mis-classified S0s are not
omitted, 25 ellipticals from RC3 classified as S0s in the Carnegie Atlas were
included in the sample. The images are 2-3 mag deeper than 2MASS images. Both
visual and photometric classifications are made. Special attention is paid to
the classification of lenses, coded in a systematic manner. A new lens-type,
called a 'barlens', is introduced. Also, boxy/peanut/x-shaped structures are
identified in many barred galaxies, even-though the galaxies are not seen in
edge-on view, indicating that vertical thickening is not enough to explain
them. Multiple lenses appear in 25% of the Atlas galaxies, which is a challenge
to the hierarchical evolutionary picture of galaxies. Such models need to
explain how the lenses were formed and survived in multiple merger events that
galaxies may have suffered during their lifetimes. Following the early
suggestion by van den Bergh, candidates of S0c galaxies are shown, which
galaxies are expected to be former Sc-type spirals stripped out of gas.Comment: 67 pages (include 16 figures and 6 tables). Accepted to MNRAS 2011
June 1
Oversizing of donor hearts: Beneficial or detrimental?
To determine the effects of donor/recipient weight mismatch on allograft function and survival after orthotopic heart transplantation, we retrospectively compared the clinical and the hemodynamic characteristics of recipients weighting more than their donor (\u27\u27undersized\u27\u27) with those of recipients weighting less than their donor (\u27\u27oversized\u27\u27). The median follow-up period was 24 months (range, 0 to 67 months). In 88 patients (59%) donor weight was 1% to 46% less than recipient weight (13.5 ± 8.9 x ± SD). In 61 patients (41%) donor weight exceeded recipient weight by 0% to 139% (20% ± 23%). When recipient ideal body weight was used in the analysis, 75 patients (51%) were undersized by 1% to 59% (13% ± 10%), and 72 patients (49%) were oversized by 0% to 67% (19% ± 18%). Preoperative transpulmonary gradient, ventricular function, and exercise tolerance were similar in the two groups. The number and severity of episodes of rejection and infection after transplantation were also similar in the two groups 1, 6, and 12 months after transplantation. When recipient ideal weight was used in the analysis, right ventricular (RV) and left ventricular (LV) ejection fractions (EFs) were within normal limits (RVEF \u3e 40%; LVEF ≥ 45%) and similar in the two groups. When recipient actual weight was used in the analysis, the LVEF measured at 12 months after heart transplantation was higher in the oversized than in the undersized group (52 ± 11 vs 46 ± 10; p \u3c 0.05). Postoperative hemodynamic values and exercise were similar in the two groups regardless of whether recipient weight or ideal body weight were used in the analysis. Forty-six recipients died 0 to 46 months (median, 7 months) after orthotopic heart transplantation. In a Cox regression model, recipients with donor weight greater than recipient ideal weight had a significantly greater risk of death within the follow-up period than did recipients with donor weight less than recipient ideal weight (relative risk = 2.19; p \u3c 0.05). When percent donor weight/recipient ideal weight mismatch was used as a continuous variable, donor heart oversizing was negatively related to survival, independent of preoperative transpulmonary gradient values (p \u3c 0.05). In contrast to common belief, oversizing of donor hearts does not improve the outcome of orthotopic heart transplant recipients who have reversible preoperative pulmonary hypertension. Acceptance of undersized donor hearts is not detrimental to allograft function and recipient survival. Use of undersized donor hearts may maximize the use of critically scarce donor organs